Cargando…
Differential effects of ginkgol C17:1 on cisplatin-induced cytotoxicity: Protecting human normal L02 hepatocytes versus sensitizing human hepatoma HepG2 cells
Liver cancer is a major healthcare problem and one of the leading causes of cancer-associated mortality in the world. To date, chemotherapy remains a common method for treating cancer and cisplatin is one of the most widely used chemotherapeutics. However, owing to drug resistance and side effects,...
Autores principales: | Li, Yueying, Zhang, Xinchi, Yang, Xiaoming, Liu, Jun, Li, Linjie, Ma, Wenbin, Chen, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396107/ https://www.ncbi.nlm.nih.gov/pubmed/30867748 http://dx.doi.org/10.3892/ol.2019.9974 |
Ejemplares similares
-
Effects of ginkgol C17:1 on cisplatin-induced autophagy and apoptosis in HepG2 cells
por: Liu, Jun, et al.
Publicado: (2018) -
In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells
por: Lu, Xun, et al.
Publicado: (2011) -
Streptozotocin-Induced Cytotoxicity, Oxidative Stress and Mitochondrial Dysfunction in Human Hepatoma HepG2 Cells
por: Raza, Haider, et al.
Publicado: (2012) -
Induction of apoptosis by Xiakemycin A in human hepatoma HepG2 cells
por: Chen, Chuan, et al.
Publicado: (2020) -
Antiproliferative and apoptotic effects of β-elemene on human hepatoma HepG2 cells
por: Dai, Zhi-Jun, et al.
Publicado: (2013)